YieldStreet, the fintech startup bringing alternative investments to the masses, has raised $62 million in financing, led by Edison Partners, the growth equity investment firm. Click to View Article
When YieldStreet launched a $6.45 million offering on its marketplace, it expected a lot of investors to get in on the deal. After all, they had about seventy-two hours to digest all the important aspects of the company and the … Continued
Dr. Patricia Fulkerson, an authority in eosinophil biology, will analyze effects of dexpramipexole in stem cell culture system Click to View Article
Knopp Biosciences LLC, a drug discovery and development company, announced the appointment of Mark Kreston as its chief commercial officer in a release. Click to View Article
Milind Mehere keeps plenty of copies of Hillbilly Elegy, J.D. Vance’s best-selling memoir about poverty in the Rust Belt, on hand for visitors to his Midtown Manhattan office. Mehere talks about how ordinary people are shut out of opportunities to … Continued
In the introductory chapter of my recently published Sports Business book, I wrote: “Because sports engender greater emotions and engagement levels than your average business, and as we consume sport differently due to technological advancements, all players within this ecosystem (sponsors, … Continued
Knopp Biosciences was featured as both the cover story, detailing the company’s recent hypereosinophilic syndrome (HES) trial, as well as in a key editorial entitled “Dexpramipexole: a new antieosinophil drug?” in the August 2, 2018 edition of Blood. The editorial, … Continued
Milford, CT, May 22, 2018 –(PR.com)– Penna, the U.K.’s foremost talent management company, now part of the Adecco group, have entered into a new service agreement with Express KCS, focused on providing expanded services into digital ad operations and campaign … Continued
Knopp Biosciences LLC today announced the publication of a report in the journal Bloodthat a Phase 2 study of dexpramipexole in hypereosinophilic syndromes (HES) met its co-primary endpoints. A team of investigators led by Dr. Amy Klion at the National Institute … Continued
“For individual investors, getting in on asset classes like commercial real estate or litigation finance has been difficult due to barriers like lack of capital. Now the technology platform and lender YieldStreet is helping accredited investors get in on asset-based … Continued
